New fluorinated and methoxylated di(hetero)arylethers and di(hetero)arylamines were prepared functionalizing the 7-position of the thieno [3,2-b] concentrations showing to be the most promising as antitumoral.
Introduction
The thienopyridine skeleton has been reported as having interesting biological activities namely antitumoral [1] [2] [3] [4] [5] [6] [7] and antiangiogenic [8] [9] [10] [11] [12] . Sugano et al. reported that the (3- amino-6-thien-2-yl-thieno [2,3-b] pyridin-2-yl)arylmethanones I showed selectivity against a tumorigenic cell line, in very low EC 50 values [1] . The methyl 3-amino-6-benzo[d] thiazol-2-ylamino)thieno [3,2-b] pyridine-2-carboxylat II was previously prepared by us and showed to be the most active compound in a series of methyl 3-amino-6-[(hetero) arylamino]thieno [3,2-b] thienopyridine-2-carboxylates [2] . In the 3-amino-6-[(hetero)aryl]thieno [3,2-b] pyridine-2-carboxylate series, compounds III and IV were shown to be the most promising compounds against MCF-7 (breast adenocarcinoma), A375-C5 (melanoma) and NCI-H460 (non-small cell lung cancer) cell lines. Indeed, compound III showed selectivity against MCF-7 and NCI-H460, presenting very low GI 50 values (1 µM) and compound IV presented GI 50 values in the 3-4 µM range for the three cell lines. The effects of compounds III and IV on the cell cycle profile of NCI-H460 cells pointed to different mechanisms of action for each compound [3] . Several methyl 3-amino-6-[(hetero) arylethynyl]thieno [3,2-b] pyridine-2-carboxylates have also been prepared by us and studied against the same human tumor cell lines, compounds Va-c being the most potent ones. Effects of these three compounds on the cell cycle profile of the NCI-H460 cells were observed and compound Vb was found to significantly induce apoptosis at its GI 50 in this cell line [4] .
Recently we have prepared methoxylated di(hetero)arylethers functionalizing the 6-position of the same thieno [3,2-b] pyridine moiety. The compounds with a methoxy group in ortho (VIa) or meta (VIb) relative to the ether function showed very low GI 50 values (1-2.5 µM). These compounds are fluorescent and have been encapsulated into 4 nanoliposomes for drug delivery purposes [5] . In another study, compound Vd showed a very low GI 50 value (1.2 µM) in the HepG2 hepatocellular carcinoma cells with no hepatotoxicity to porcine liver primary cells. Effects of this compound on the cell cycle of HepG2 were verified [6] . By functionalizing the amino group of the 3-aminothieno [3,2-b] pyridine-2-carboxylate, several amino diarylamines were obtained.
Among them, compound VII was the most active presenting very low GI 50 values (1 µM) for all the cell lines referred above including HepG2, without hepatotoxicity to porcine liver primary cells. Effects on the cell cycle profile of the NCI-H460 cells treated with compound VII were observed [7] . N-(1H-indol-5-yl)-2-arylthieno[3,2-b] pyridin-7-amines [8] , aminothieno [3,2-c ]pyridine 1,3-diarylureas [9] , thieno [3,2-b] pyridine arylethers phenylacetylthioureas [10] , thieno [3,2-b] pyridine arylethers N 3 -arylmalonamides [11] , and N- (3-fluoro-4-(2-5 arylthieno [3,2-b] pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides [12] have been previously described as inhibitors of the vascular endothelial growth factor receptor (VEGFR-2), a mediator of the biological function of the vascular endothelial growth factor (VEGF), related to angiogenesis and metastasis.
Structures of compounds I-VII
In the present study, new fluorinated and methoxylated di(hetero)arylethers and di(hetero)arylamines were prepared by functionalizing the 7-position of the thieno [3,2-b] pyridine, using copper (C-O) or palladium (C-N) catalyzed couplings, respectively.
The compounds were evaluated for their growth inhibitory activity towards human tumor cell lines, and the most active ones were further studied regarding their effects on NCI-H460 cell cycle profile and programmed cell death. The hepatotoxicity of the compounds was assessed using non-tumor porcine liver primary cells.
Results and discussion

Synthesis
The reaction of the 7-bromothieno [3,2-b] pyridine (1), also prepared by us from the commercial thieno [3,2-b] pyridin-7-ol and POBr 3 , with methoxy or fluorophenols and anilines gave rise in moderate to good yields to the new di(hetero)arylethers 2a-f, by a copper-catalyzed (C-O) Ullmann coupling with N,N-dimethyl glycine as the ligand [13] , previously used by us in the synthesis of other di(hetero)arylethers [5] , and in good to high yields to the new di(hetero)arylamines 3a-f by a palladium-catalyzed (C-N)
Buchwald-Hartwig coupling [14] with BINAP as the ligand, usually performed in our group [2] (Scheme 1). 
Growth inhibitory activity on human tumor cell lines and on porcine liver primary cells
The tumour cell growth inhibitory activity of the di(hetero)arylethers 2a-f and di(hetero)arylamines 3a-f was evaluated in five human tumor cell lines: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung carcinoma), HCT15 (colon adenocarcinoma), HepG2 (hepatocellular carcinoma) and HeLa (cervical carcinoma) using the sulforhodamine B assay as previously described [2] [3] [4] [5] [6] [7] . This allowed the determination of the GI 50 values (µM), corresponding to the concentration of the compounds which inhibited 50% of cell growth ( Table 1) . Furthermore, the toxicity of the compounds towards non-tumor cells was studied using porcine liver primary cells (PLP2) . From the results obtained ( Table 1) it is possible to establish some structure-activity The most active compounds in the tumor cell lines, 2e, 3d and 3e, were chosen to be further studied regarding their effect on cell cycle profile and programmed cell death on 9 one of the most sensitive cell lines, NCI-H460. This cell line was also chosen since it represents non-small cell lung cancer, one of the cancers which currently cause most deaths worldwide.
Effects on cell cycle profile and programmed cell death of NCI-H460 cells
Treatment of NCI-H460 cells with the GI 50 concentration of compounds 2e, 3d and 3e
showed that all the compounds caused pronounced alterations in the cell cycle profile of these cells (Figure 1 ). In addition, a shoulder in the left of the G1 peak was evident following treatment with all the compounds, which was indicative of a sub-G1 peak and suggestive of cell death.
This was further confirmed with the TUNEL assay. Indeed, a strong and significant increase in programmed cell death was observed following 24h and 48h of treatment with the compounds (Figure 2 ). When cells were treated with the compounds for 24h, compounds 3d and 3e caused a stronger increase than compound 2e in the levels of cell death. However, when cells were treated for 48h all compounds caused similar effects in the levels of cell death, which was higher than 30%.
10 experiments. Statistical significance was tested by two tailed paired Student's t-Test using DMSO as a negative control. * Indicates p<0.05.
Conclusions
The fluorinated and methoxylated di(hetero)aryl)ethers and di(hetero)arylamines were prepared by copper (C-O) or palladium (C-N) catalyzed couplings of 7-bromothieno [3,2-b] pyridine with ortho, meta and para fluoro or methoxy phenols or anilines in moderate to high yields, after chromatographic purification and were fully characterized. The compounds obtained were evaluated for their growth inhibitory activity on several human tumor cell lines. The most active compounds, were shown to be a di(hetero)arylether with a methoxy group in the meta position relative to the ether function and two di(hetero)arylamines with a methoxy group either in the ortho or in the meta position relative to the NH. These were further tested at their GI 50 concentrations on NCI-H460 cells causing pronounced alterations in the cell cycle profile and a strong and significant increase in the programmed death of these cells. The fluorinated and the other methoxylated compounds presented high GI 50 values in all the cell lines tested. Furthermore, the toxicity of the compounds was assessed using porcine liver primary cells (PLP2). The results showed that one of the most active compounds, the di(hetero)arylether 2e, was non toxic to non-tumor cells at their GI 50 concentrations, compound 2e being the most promising antitumoral. The toxicity of the two di(hetero)arylamines 3d and 3e needs to be further studied. 
Materials and Methods
Chemistry
Melting points ( o C) were determined in a Stuart SMP3 and are uncorrected. 1 H and 13 CNMR spectra were recorded on a Varian Unity Plus at 300 and 75.4 MHz, respectively or on a BrukerAvance III at 400 and 100.6 MHz, respectively. Two (2.80 g, 10.0mmol ) and the mixture was heated at 65 ºC for 6h. After cooling, NaOH (aq) (5mL), water (5mL) and chloroform (5mL) were added. The phases were separated and the aqueous phase was extracted with more chloroform (2×5mL). 
General procedure for the synthesis of di(hetero)arylethers 2a-f:
A dry Schlenk tube was charged under Ar with dry dioxane (3 mL), the fluoro or methoxyphenol (1.1 equiv.), N,N-dimethylglycine (30 mol%), CuI (20 mol%), Cs 2 CO 3 (2 equiv.) and compound1. The mixture was heated with stirring under Ar at 100 ºC for 18h. After cooling water (5mL) and ethyl acetate (5mL) were added. The phases were separated and the aqueous phase was extracted with more ethyl acetate (2×5mL). The organic phase was dried (MgSO 4 ) and filtered. Removal of the solvent gave anoil which was submitted to column chromatography. and ethyl acetate (5mL) were added. The phases were separated and the aqueous phase was extracted with more ethyl acetate (2×5mL). The organic phase was dried ( MgSO 4 ) and filtered. Removal of the solvent gave a solid which was submitted to a dry flashin silica using ether or AcOEt and a solid was obtained. 1H, 6-H), 7.20-7.24 (m, 2H, 3' and 5'-H), 7.29-7.32 (m, 2H, 2' and 6'-H) ii)DMEM supplemented with 10% FBS, 2 mM glutamine, 100 U/mL penicillin and 100 mg/mL streptomycin, for HeLa and HepG2 cells). To assess the growth inhibitory activity of the compounds, the Sulforhodamine B assay was performed according to a procedure previously described by the authors [2] [3] [4] [5] [6] [7] . For this, each cell line was plated at an appropriate density (7. For the evaluation of toxicity towards non-tumor cells, a primary cell culture was prepared from a freshly harvested porcine liver obtained from a local slaughter house, according to a procedure previously established by some of us [6, 7] ; these cells were designated as PLP2 cells. Cell culture was continued with direct monitoring every two to three days using a phase contrast microscope. Before confluence was reached, cells were sub-cultured and plated in 96-well plates at a density of 1.0×10 4 cells/well, and culturedin DMEM medium with 10% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin. Cells were treated for 48 h with the different compounds solutions and the procedure for SRB assay was followed, as described above. The results were expressed in GI 50 values (concentrations that inhibited 50% of the net cell growth).
7-(2-flurophenoxy)thieno[3,2-b]pyridine (2a):
7-(3-flurophenoxy)thieno[3,2-b]pyridine (2b):From
Ellipticine was used as positive control.
Analysis of cell cycle profile and programmed cell death
NCI-H460 cells (1×10 5 cells/well) were plated in 6-well plates and incubated at 37º C for 24 h. Cells were then treated with complete medium (blank), with the compounds (2e, 3d and 3e)) at their previously determined GI 50 concentrations or with their respective vehicle (DMSO, control). Cells were harvested following a 24 h and/or 48 h and further processed according to the following protocols.For cell cycle profile analysis, following 24 h treatment cells were fixed in 70% ice-cold ethanol and kept at 4ºC for at least 12 h until analysis. Prior to analysis, cells were incubated with Propidium Iodide (5 µg/mL) and RNaseA in PBS (100 µg/ml) for 30 min on ice [11] .
Cellular DNA content was analyzedusing a FACSCalibur (BD) flow cytometer. Cell cycle profile was subsequently analyzedusing the FlowJo 7.6.5 software (Tree Star, Inc., Ashland, OR, USA) after cell debris and aggregates exclusion [3, 4] .
22
For programmed cell death analysis, following 24h and 48 h treatment cells were fixed in 4% paraformaldehyde for 30 minutes and further kept in PBS at 4 ºC until analysis.
Cytospins were then prepared and cells permeabilized in ice cold 0.1% Triton X-100in 0.1% sodium citrate for 2 min. Programmed cell death was assessed using the "in situ cell death detection kit-fluorescein" (Roche, Basel Switzerland).Briefly, cells were incubated with the TUNEL reaction mix (enzyme diluted 1:20) for 1 h, as previously described [12] . Slides were mounted with Vectashield Mounting Media with DAPI (Vector Laboratories). Cells were observed in a DM2000 microscope (LEICA) and a semi-quantitative evaluation of the levels of programmed cell death was performed by counting a minimum of 500 cells per slide, except in the cases of 2e and 3d treatment at 48h, in which only ~300 cells were counted.
Statistical analysis
Results were expressed as mean ± standard deviation (SD) or standard error (SEM) of at least three independent experiments, performed in duplicate. Statistical significance was tested with a two tailed paired Student's t-Test in relation to control (DMSO treatment).
* p<0.05.
